A top pharmaceutical company partnered with Sedulo Group to leverage pharma competitive intelligence and outmaneuver competitors in a high-stakes product launch.
Pharmaceutical Leader Advances Parkinson’s Therapies with Competitive Intelligence
Sedulo crafted an early-warning monitoring program for a pharma leader focused on Parkinson’s stage therapies. Through secondary intelligence (press releases, clinical data) and primary interviews with competitor personnel, the team flagged key R&D moves, enabling the client to pivot proactively in a fast-evolving treatment space
Strategic Intelligence Equips Cardiovascular Client to Navigate Market Disruption from New Entrants and Generics
A U.S.-based biopharmaceutical company faced competitive pressure from upcoming cardiovascular product launches and looming generic entry. Sedulo Group delivered targeted intelligence on competitor strategies, generic threats, and market vulnerabilities through a customized monitoring program. Armed with these insights, the client implemented counter-launch tactics, adjusted pricing and distribution, and protected its market position
Innovative Pharma Company Navigates Evolving Pain Market with Targeted Competitive Insights
To navigate a fast-changing chronic pain market, a leading pharma company partnered with Sedulo for targeted competitive intelligence, gaining timely insights that shaped strategy across brand, CI, and market access teams.
Embedded Competitive Intelligence Program Powers Oncology Rare Disease Launch
To support a successful oncology product rollout, Sedulo implemented a fully integrated CI program. Designed for launch-readiness, it provided real-time, actionable insights across commercialization stages, from competitive launches to positioning strategy, helping the client stay steps ahead of industry shifts
Biotech Company Improves Competitive Awareness and Launch Readiness in Alzheimer’s and Schizophrenia Market
In this early‑Alzheimer’s therapeutic space, Sedulo deployed a targeted intelligence initiative combining secondary research and trial data with primary interviews. The result was proactive flagging of competitor R&D moves and potential partnerships, informing strategic planning in a rapidly evolving market.
Global 2000 Pharma Company Partners with Sedulo for PAH Competitive Landscape Intelligence
Leveraging a dual approach of secondary research and Primary Research using Sedulo’s Persistent Source Network™, this project delivered a comprehensive landscape intelligence program for PAH. It mapped evolving competitive pipelines, differentiators, and trial activity to support strategic decision-making in a complex therapeutic area.
Leading Pharmaceutical Company Transforms their Strategy with Sedulo Group’s Digital Health Monitoring Program
Sedulo created a digital health monitoring system for a top‑20 pharma client. Over 18 months, desk research and primary interviews yielded executive-ready monthly insight reports and flash alerts across key categories like trial innovation, diagnostic advances, and payer value mapping.
Staying Ahead of the Curve: A Biopharmaceutical Company’s Winning Pulmonary Monitoring Strategy
To enhance remote pulmonary monitoring, Sedulo integrated clinical insights and technology landscape signals. By assessing existing tools and emerging biosensors, the program offered strategic guidance on partner selection and roadmap development in respiratory telehealth.
Gaining a Competitive Edge in Digital Health: A Top 20 Pharma Company’s Winning Strategy
Sedulo designed a comprehensive digital-health strategy for a major pharmaceutical company. Through continuous surveillance of clinical trial design, payer frameworks, and hospital algorithm implementations, the team scored competitor digital capabilities across 12 categories, enabling data-driven investment and market positioning.
- Page 1 of 2
- 1
- 2